* Singular Genomics Systems Inc OMIC.OQ OMIC.O is
expected
to show a fall in quarterly revenue when it reports results on
August 13 for the period ending January 1 0001
* The San Diego California-based company is expected to
report a
20.8% decrease in revenue to $400 thousand from $505 thousand a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Singular Genomics
Systems Inc
is for a loss of $8.86 per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $6.50, below its last closing price of $7.51.
This summary was machine generated August 9 at 23:09 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)